For optimally engineered tissues, it is important that biological cues are delivered with appropriate timing and to specific locations. To aid in this endeavor, researchers have combined acoustic droplet ejection (ADE) technology with 3-D printing to establish stringently controlled growth factor patterning in porous constructs. Their work is reported in Tissue Engineering.
In “Acoustic Patterning of Growth Factor for 3-D Tissue Engineering,” Yunzhi Peter Yang, Ph.D., Stanford University, and coauthors report the establishment of this new combination method. The authors started with biodegradable polycaprolactone (PCL) constructs, which were terminated with succinimide as test material or with sodium hydroxide or fibrin as controls, and then used ADE to deposit bone morphogenetic protein 2 (BMP-2) in precise locations throughout the lattice. C2C12 mouse myoblast cells were incubated with the constructs, and the osteogenic differentiation of these cells was monitored by alkaline phosphatase (AP) staining. The PCL-succinimide samples showed AP staining mirroring the patterned BMP-2 spots, thus demonstrating the potential of ADE growth factor patterning in tissue engineering.
“This novel combination of 3-D printing and ADE technologies addresses the crucial need for high spatial resolution of growth factor presentation in tissue engineered constructs,” says Tissue Engineering Co-Editor-in-Chief Antonios G. Mikos, Ph.D., Louis Calder Professor at Rice University, Houston, TX. “While the use of this technology demonstrated great success in osteogenic differentiation, these techniques will also be tremendously beneficial to many other tissue types as well.”
Yaser Shanjani et al, Acoustic Patterning of Growth Factor for Three-Dimensional Tissue Engineering, Tissue Engineering Part A (2020). DOI: 10.1089/ten.tea.2019.0271
Acoustic growth factor patterning (2020, April 15)
retrieved 15 April 2020
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022